SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

AVDLSell

Avadel Pharmaceuticals Plc

Weiss Asset Management LP · Former 10% Owner

$233.4M−100.0%Feb 18
AVDLBuy

Avadel Pharmaceuticals Plc

Linda Palczuk · Director

$40K+8.0%Jan 22
AVDLBuy

Avadel Pharmaceuticals Plc

Peter J. Thornton · Director

$80K+11.0%Jan 14
AVDLBuy

Avadel Pharmaceuticals Plc

Eric J Ende · Director

$235K+17.0%Jan 14
AVDLBuy

Avadel Pharmaceuticals Plc

Thomas S Mchugh · CFO

$52K+6.0%Dec 12
AVDLBuy

Avadel Pharmaceuticals Plc

Gregory J Divis · CEO

$100K+6.0%Dec 10
AVDLBuy

Avadel Pharmaceuticals Plc

Geoffrey Michael Glass · Director

$200K+30.0%Dec 10
AVDLBuy

Avadel Pharmaceuticals Plc

Linda Palczuk · Director

$31K+5.0%Dec 10
AVDLBuy

Avadel Pharmaceuticals Plc

Thomas S Mchugh · CFO

$29K+3.0%Jan 16
AVDLSell

Avadel Pharmaceuticals Plc

Mark Anthony Mccamish · Director

$1.1M−53.0%Dec 29
AVDLSell

Avadel Pharmaceuticals Plc

Mark Anthony Mccamish · Director

$433K−17.0%Aug 15
AVDLBuy

Avadel Pharmaceuticals Plc

Thomas S Mchugh · CFO

$29K+3.0%Aug 14
AVDLBuy

Avadel Pharmaceuticals Plc

Geoffrey Michael Glass · Director

$188K+13.0%Aug 11
AVDLBuy

Avadel Pharmaceuticals Plc

Gregory J Divis · CEO

$132K+7.0%Aug 10
AVDLBuy

Avadel Pharmaceuticals Plc

Eric J Ende · Director

$181K+8.0%May 19
AVDLBuy

Avadel Pharmaceuticals Plc

Linda Palczuk · Director

$37K+5.0%May 10
AVDLBuy

Avadel Pharmaceuticals Plc

Geoffrey Michael Glass · Director

$96KJun 3
AVDLBuy

Avadel Pharmaceuticals Plc

Geoffrey Michael Glass · Director

$96K+68.0%Jun 2
AVDLBuy

Avadel Pharmaceuticals Plc

Eric J Ende · Director

$78K+35.0%Jun 1
AVDLBuy

Avadel Pharmaceuticals Plc

Thomas S Mchugh · CFO

$51K+75.0%Sep 1
AVDLBuy

Avadel Pharmaceuticals Plc

Geoffrey Michael Glass · Director

$33K+8.0%Sep 1
AVDLBuy

Avadel Pharmaceuticals Plc

Thomas S Mchugh · CFO

$78KAug 17
AVDLBuy

Avadel Pharmaceuticals Plc

Eric J Ende · Director

$39K+8.0%Aug 17
AVDLBuy

Avadel Pharmaceuticals Plc

Geoffrey Michael Glass · Director

$100K+27.0%Aug 14
AVDLBuy

Avadel Pharmaceuticals Plc

Eric J Ende · Director

$116K+31.0%Aug 13
AVDLBuy

Avadel Pharmaceuticals Plc

Gregory J Divis · CEO

$101K+15.0%Aug 13
AVDLBuy

Avadel Pharmaceuticals Plc

Eric J Ende · Director

$60K+26.0%Dec 5
AVDLBuy

Avadel Pharmaceuticals Plc

Linda Palczuk · Director

$44K+27.0%Dec 5
AVDLSell

Avadel Pharmaceuticals Plc

Michael S Anderson · CEO

$80K−6.0%Aug 14
AVDLSell

Avadel Pharmaceuticals Plc

Sandra L Hatten · Insider

$31K−12.0%Aug 14
AVDLSell

Avadel Pharmaceuticals Plc

James E Flynn · *Possible member of 10% group, 10%

$683K−3.0%Jun 25
AVDLBuy

Avadel Pharmaceuticals Plc

Craig R Stapleton · Director

$1.2M+39.0%Dec 19
AVDLBuy

Avadel Pharmaceuticals Plc

Michael S Anderson · CEO

$44K+2.0%Dec 11
AVDLSell

Avadel Pharmaceuticals Plc

Craig R Stapleton · Director

$2.4M−41.0%Nov 29
AVDLBuy

Avadel Pharmaceuticals Plc

Peter J. Thornton · Director

$50KSep 25
AVDLBuy

Avadel Pharmaceuticals Plc

Sandra L Hatten · Insider

$56K+17.0%Sep 15
AVDLBuy

Avadel Pharmaceuticals Plc

Phillandas T. Thompson · Insider

$47K+9.0%Sep 14
AVDLBuy

Avadel Pharmaceuticals Plc

Craig R Stapleton · Director

$190K+3.0%Sep 14
AVDLBuy

Avadel Pharmaceuticals Plc

Michael S Anderson · CEO

$39K+2.0%Sep 14
AVDLBuy

Avadel Pharmaceuticals Plc

Greg J Divis · Insider

$99KSep 14
AVDLSell

Avadel Pharmaceuticals Plc

Broadfin Healthcare Master Fund Ltd · 10% owner

$2.8M−6.0%Jun 26
AVDLSell

Avadel Pharmaceuticals Plc

Guillaume Cerutti · Director

$278K−53.0%Jun 19
AVDLBuy

Avadel Pharmaceuticals Plc

Michael S Anderson · CEO

$25K+1.0%May 22
AVDLBuy

Avadel Pharmaceuticals Plc

Craig R Stapleton · Director

$305K+5.0%May 22

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.